Focused on developing treatments for musculoskeletal pain, the company specialized in localized, extended‑release therapies designed to improve outcomes for patients with osteoarthritis. Its lead product, Zilretta, is an extended‑release corticosteroid injection for knee osteoarthritis that generate...
No congressional trades have been disclosed for Flexion Therapeutics Inc (FXLX) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.